Industry symposia

The IDF World Diabetes Congress 2025 features 130 hours of scientific sessions, with more than 250 international speakers including some of the top experts in diabetes today.

Industry symposia are an integral part of the congress programme, offering high-quality content and high-level speakers.

Companies operating in the field of diabetes value IDF Congresses as relevant and impactful opportunities to present the latest research and share innovative products with an international audience of health professionals.

Browse the full industry symposia programme below.

All times ICT (UTC+7).

Monday, April 7
14:30-16:15
Silk 1

Diabetes in Asia: Understanding Risk, Environment, and Innovative Management Strategies in China and Beyond

Tuesday, April 8
12:30-13:30
Grand Hall 202

Optimizing Care in Heart Failure, Chronic Kidney Disease and Diabetes with non-steroidal MRAs

Programme

Chairs: Linong Ji (China), Alice Cheng (Canada)
Welcome and introduction

Kidney disease in Type 1 and Type 2 Diabetes: Bridging the gaps
Per-Henrik Groop (Finland)

New paths to improve outcomes in heart failure
John McMurray (UK)

Programme

Non-steroidal MRAs in cardiovascular, kidney, and diabetes care: practical considerations
Luc van Gaal (Belgium)

Discussion & Closure
Alice Cheng (Canada)

Organized by Sciarc, kindly supported by Bayer AG.

Tuesday, April 8
12:30-13:30
Amber

Shape the future of Nerve Health - Empower the patient

Programme

Welcome and introduction

The burden of diabetic peripheral neuropathy
Prof Rayaz Malik (Qatar)

The new ACT tool – empowering the patient to act
Dr. Hoda Gad (Qatar)

Solving the puzzle of diabetic peripheral neuropathy
Panel discussion, international expert panel

Tuesday, April 8
12:30-13:30
Nile 2

The Beauty and Opportunity of Breath Ketone to Transform Diabetes Care

Programme

Welcoming remarks and brief introduction
Dr Christine Yip, CEO & Founder of AusMed Global (China)

Ketone measurements in diabetes management
Prof Lee Chi Ho Paul (Hong Kong)

The Synergy of digital twin technology and breath ketone measurement for diabetes care
Prof Joe Dong (Hong Kong)

Programme

Efficacy and safety of GLP1Ra combination therapy: a population-based cohort study
Prof Gary Tse (Hong Kong)

Question & Answers
Dr Christine Yip and faculty

Tuesday, April 8
17:30-19:30
Nile 2

Global Health session “How Private Sector Can Help Improve Access to Health Care: A Case of Lilly”

Programme

Access to healthcare landscape – supply- and demand-side barriers to access

Strategic collaborations to advance access to health care – LFAC/DR Cold Chain, A4D

Access expansion to insulins – collaboration with EVA Pharma

VLA as an access expansion tool

Programme

Panel discussion
WHO PQ or Regional Offices, Life for A Child, Action for Diabetes, EVA Pharma, Egypt MOH.)

Question & Answer

Tuesday, April 8
12:30-13:30
Silk 1

How to get early glycemic control? New data & perspectives

Programme

Chair: Kamlesh Khunti (UK)
Introduction

Glycemic control and Cardiorenal benefits: Together or one over the other?
Ashwani Mehta (India), Juliana Chan (Hong Kong)

The paramount importance of Glycemic control: What are our options?
Mohamed M Hassanein (UAE)

Programme

Simplifying adherence for people with type 2 diabetes: What are the unmet needs ?
Somia Iqtadar (Pakistan), Narsimha Raju Dichpally (India)

Discussion

Wednesday, April 9
12:30-13:30
Grand Hall 202

Revolutionizing Diabetes Care with CGM: Innovation for Accessibility and Ease

Programme

Opening and Introduction

CGM as the Standard of Care
Prof. Satish Garg (USA)

CGM to Elevate Quality of Life
Prof. Alice Cheng (Canada)

CGM Access for All?
Dr. Viswanathan Mohan (India)

Q&A and Closing
All faculty

Wednesday, April 9
12:30-13:30
Amber

Holistic and connected diabetes management: Insights from the patient’s perspective

Programme

Chair: Abdul Basit (Pakistan)
The transformative impact of emotional support and education of digital diabetes technology

Empowering patients through blood glucose monitoring: fostering ownership and enhancing lifestyle behaviors.

Collaboration in action: Bridging healthcare support and patient-driven decisions in diabetes management

Wednesday, April 9
17:30-19:00
Nile 1

Optimizing Combination Therapy in T2DM: Maximizing Benefits of Combination therapy in South Asian Population

Programme

Welcome and introduction

Evolution of Combination Therapy: Evidence-Based Approach to Diabetes Management

Optimizing Patient Outcomes: When and How to Initiate

Beyond Glycemic Control: Cardiovascular and Renal Benefits of Modern treatment

Discussion Practical Challenges and Solutions in Diabetes Management

Wednesday, April 9
12:30-13:30
Silk 1

Metformin and Insulin Resistance: Bridging Science and Clinical Practice

Programme

Welcome and introduction
Chaicharn Deerochanawong (Thailand)

Metformin in early and impending diabetes
Nemencio Nicodemus (the Philippines)

Metformin in PCOS
Anju Joham (Australia)

Metformin during pregnancy
Dittakarn Boriboonhirunsarn (Thailand)

Thursday, April 10
12:30-13:30
Silk 2

Life for a Child Program update, including analogue insulin studies with partners